SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Cancer diagnosis risk for women with sleep apnoea
Tues May 21st - Women with obstructive sleep apnoea are more likely to be diagnosed with cancer than men with the condition, according to Greek research published last night. More
Technique uncovers signs of potentially fatal cardiac arrest
Tues May 21st - A brain imaging technique has been used for the first time to help identify the signs of hypertrophic cardiomyopathy, a UK study revealed last night. More
RECENT COMMENTS
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
OTHER NEWS FEEDS OF INTEREST
ENGLEMED HEALTH NEWS

Extend anti-hypertensive medication - guidance

Friday March 8th, 2019

Up to 700,000 extra people could be advised to take anti-hypertensive medicines in a major shift of guidance published today.

According to the new guidance, drugs should be prescribed for patients with stage 1 hypertension and a relatively low risk of developing cardiovascular disease.

The risk threshold advised by the National Institute for Health and Care Excellence has been 20% over a ten-year period – but today's advice reduces it to 10%.

NICE says it believes about 450,000 men and 270,000 women may fall into this new category – although many may already be receiving treatment.

In today's draft guidance, NICE says it has decided not to reduce the blood pressure threshold for medication from 140/90mmhg because of the ambiguity of studies suggesting benefits from doing so.

The guidance is to be subject to consultation and will be examined closely by GP leaders.

Professor Anthony Wierzbicki, of Guy's and St Thomas', who led the guideline committee, said: “The guideline effectively shifts the focus to earlier intervention with lifestyle or drug treatment because this may slow the age-related deterioration of blood pressure. This would keep people well for longer and reduce the long-term need for multiple medications.

"The guideline also places a greater emphasis on achieving and maintaining blood pressure targets as many people with high blood pressure are undertreated.”

The Royal College of GPs said the new guidance would need "careful consideration."

Chair Professor Helen Stokes-Lampard said: “Lowering the threshold for making a diagnosis of hypertension, or high blood pressure – a condition that already affects a very large number of patients in the UK - is likely to affect thousands, if not millions of patients, so this decision must not be taken lightly and must be evidence-based.

“Clinical guidelines are regularly updated to take into account the most current research and make recommendations of how to implement it in the best interests of patients. Now that this draft guideline is open for consultation, we would encourage experts in the area to respond to express their views.

“We know that weight control, careful diet, and better exercise habits all remain key ways to prevent or reduce hypertension. GPs already advocate healthy lifestyle changes and discuss these with their patients where possible within the constraints of a standard 10-minute appointment."

Tags: Heart Health | NHS | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES